KRAS and rectal cancer: However, in the present rectal cancer patient with wild-type KRAS and no MSI, we discovered a novel BRAF mutation that led to a triplet deletion of the coding nucleotides 1799–1801 (TGA1799–1801 deletion; VK600–601E).